본문으로 건너뛰기
← 뒤로

Extended indications for functional limb-sparing surgery in extremity sarcoma using complex reconstruction.

Archives of surgery (Chicago, Ill. : 1960) 1992 Vol.127(11) p. 1278-81

Paz IB, Wagman LD, Terz JJ, Chandrasekhar B, Lorant JA, Moscarello GM, Odom-Maryon T

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Paz IB, Wagman LD, et al. (1992). Extended indications for functional limb-sparing surgery in extremity sarcoma using complex reconstruction.. Archives of surgery (Chicago, Ill. : 1960), 127(11), 1278-81. https://doi.org/10.1001/archsurg.1992.01420110020005
MLA Paz IB, et al.. "Extended indications for functional limb-sparing surgery in extremity sarcoma using complex reconstruction.." Archives of surgery (Chicago, Ill. : 1960), vol. 127, no. 11, 1992, pp. 1278-81.
PMID 1444786

Abstract

From 1980 to 1991, 29 patients underwent complex reconstruction following extremity sarcoma resection. Soft tissue was the site of origin in 15 patients (52%) and bone was the site of origin in 14 patients (48%), with 20 sarcomas (69%) in the lower extremity. Resection consisted of the following procedures: extended anatomical soft-tissue resections (21 patients [72%]), bone resections (18 patients [62%]), and joint resections (14 patients [48%]). Reconstruction involved the following: myocutaneous flaps (20 patients [69%]), joint prosthesis (eight patients [28%]), and bone reconstruction (15 patients [52%]). There was no surgical mortality; one patient required an amputation owing to surgical complications. The site of the first failure was local (four [31%] of 13 patients), lung (five patients [38%]), others (four patients [31%]). At a median follow-up of 23 months, 18 patients (62%) had no evidence of disease, 27 (93%) had no local disease, 21 (72%) had good extremity function, three (10%) had major disabilities, and five (17%) underwent amputations. Local control improved when the margin of resection was larger than 10 mm. Disease-free survival was 67% at 3 years. Overall survival was 51% at 5 years. Tumor size was an independent predictor of overall survival. Local recurrence did not affect overall survival.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
해부 Soft tissue scispacy 1
해부 bone scispacy 1
해부 lung scispacy 1
합병증 soft-tissue resections scispacy 1
합병증 myocutaneous flaps scispacy 1
질환 sarcoma C1261473
Sarcoma
scispacy 1
질환 sarcomas C1261473
Sarcoma
scispacy 1
질환 major disabilities scispacy 1
질환 amputations C0002688
Amputation
scispacy 1
질환 Tumor C0027651
Neoplasms
scispacy 1
질환 disease scispacy 1
기타 joint scispacy 1

MeSH Terms

Adult; Aged; Bone Neoplasms; Bone Transplantation; California; Chemotherapy, Adjuvant; Combined Modality Therapy; Extremities; Female; Follow-Up Studies; Humans; Joint Prosthesis; Male; Middle Aged; Neoplasm Recurrence, Local; Orthopedics; Postoperative Complications; Prognosis; Radiotherapy; Sarcoma; Soft Tissue Neoplasms; Surgery, Plastic; Surgical Flaps; Survival Rate; Treatment Outcome